| Revenue growth | 3% YoY growth in FY26; 1% in Q4. |
|---|---|
| Margins | Record levels: Gross Margin 42.3%, EBITDA 19.6%, PAT 16.3% for Q4. |
| Demand visibility | Cautiously optimistic for FY27; dependent on monsoon arrival and distribution. |
| Management confidence | High; described stability in an unstable environment and sustainable record margins. |
Growth
FY26 Revenue grew 3% YoY to ₹3,238cr; PAT rose 7% to ₹543cr; EBITDA margin hit record 20.7%.
Outlook
Ongoing ₹150cr Dahej capex; plans to launch new biostimulant 'Top Grain' and molecules from parent's discovery pipeline.
Risks
Adverse monsoon forecasts (92% of LPA), El Nino probability, and escalating raw material/logistics costs due to geopolitical tensions.
Last quarter's promises, checked
Delivered
- Guided H1 growth → delivered 9% sales & 11% profit growth (= BEAT)
- Guided 4-5 product launches/year → delivered 7 products in FY26 (= BEAT)
- Guided stable pricing despite monsoon → delivered stable pricing YoY (= BEAT)
Partly delivered
- Guided ₹120cr capex commercialization → Bhavnagar complete, Tarapur export delayed (= PARTIAL)
Missed
- Guided robust Q2 performance → delivered slight revenue decline to ₹930cr (= MISS)
Earnings Call filed with NSE, NSE: SUMICHEM. Summary written with AI assistance from the document.
Sumitomo Chemical India Ltd: key numbers
- Share price
- ₹421.90
- Market cap
- ₹21,059 Cr
- Revenue (annual)
- ₹3,238 Cr
- Net profit (annual)
- ₹543.0 Cr
- P/E (TTM)
- 36.3×Sector 37.2×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.89%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sumitomo Chemical India Ltd
All →Sumitomo Chemical India Investor Presentation: Key Takeaways
Sumitomo Chemical reported resilient Q1FY27 results despite a difficult domestic operating environment. Revenue grew 1% to ₹1,063 cr, while Net Profit surged 20% to ₹215 cr, aided by an insurance claim.
Sumitomo Chemical India Annual General Meeting
Sumitomo Chemical India Ltd. held its 26th Annual General Meeting on July 27, 2026. Shareholders transacted ordinary and special business, including director appointments and dividend declaration.
Sumitomo Chemical India Management Change
Mr. Ninad D. Gupte has resigned as a Non-Executive, Non-Independent Director of Sumitomo Chemical India Ltd. The resignation is effective from August 31, 2026.
Sumitomo Chemical India Board Meeting Date
Sumitomo Chemical India Ltd announced a Board meeting on 27 July 2026. Agenda includes the unaudited Q1‑2026 financial results.
Sumitomo Chemical India Annual Report
Sumitomo Chemical India released its FY 2025-26 Annual Report, reporting ₹31.9 billion revenue and a market cap of ₹182,038.45 million. The report highlights stable performance despite climatic challenges.
- Value
- ₹3,190 Cr
Sumitomo Chemical India Annual Report
Sumitomo Chemical India Ltd released its Annual Report for FY 2025-26, highlighting stable performance and ₹31.9 billion revenue. The report details global footprints and future growth strategy.